
Key points:
·Law enforcement action initiated: The Malaysian Ministry of Health will launch Operation Selamat Paru-Paru on August 1 to strengthen e-cigarette regulation.
·Lung cancer data: From 2022 to 2023, there were 8091 cases of lung cancer in Malaysia, with 5251 cases in males and 2840 cases in females.
·State government measures: Some state governments have decided to no longer renew e-cigarette sales licenses, a move welcomed by the Health Minister.
·Ban on open systems: The Ministry of Health is considering implementing a ban on open systems due to their allowing users to add unregulated substances.
·Case investigations: As of June 2025, a total of 58 e-cigarette cases have been investigated, with nearly 70% of e-liquids testing positive for prohibited substances.
·Consideration of a comprehensive ban: The Ministry of Health is considering implementing a more extensive comprehensive ban, prohibiting the use and sale of e-cigarette products, requiring new legislative proposals.
【2Firsts News Flash】According to thevibes.com's report on July 28, the Malaysian Ministry of Health will be launching a nationwide enforcement operation, Op Selamat Paru-Paru (Operation Save Lungs), on August 1 to strengthen the implementation of the Public Health (Control of Tobacco Products) Regulations 2024 (Act 852), with a focus on regulating e-cigarettes.
Minister of Health Datuk Seri Dr Dzulkefly Ahmad stated that the initiative aims not only to protect predominantly male smokers, but also hopes to safeguard women and children who are exposed to the harms of secondhand smoke. According to data from the National Cancer Registry, there were 8,091 cases of lung cancer recorded between 2022 and 2023, including 5,251 male cases and 2,840 female cases.
Zucciferri welcomed the decisions of several state governments to no longer renew e-cigarette sales licenses, referring to it as a "positive step" in supporting public health.
Zuki Fili revealed that the Ministry of Health is considering immediately implementing a ban on open system e-cigarettes, which allow users to modify or add unregulated substances.
“As of June 2025, a total of 58 cases have been investigated. Nearly 70% of the e-liquids tested were found to contain prohibited substances, including methamphetamine and synthetic cannabinoids.”
He said.
Health Minister Zulkipli revealed in a subsequent press conference that the Ministry of Health is considering implementing a broader and long-term comprehensive ban on the use and sale of e-cigarette products in Malaysia. He further clarified that Act 852 is a regulatory law and does not include provisions for a ban on sales. If a total ban is to be imposed, a new legislative proposal would need to be put forward.
He added that any proposed bans will take into consideration various factors, including scientific and medical data, cases of lung damage related to e-cigarette use, legal implications, economic impacts on the e-cigarette industry, and the feasibility of enforcement.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com